97 related articles for article (PubMed ID: 171348)
1. 5-Hydroxytryptophan and sleep in Down's syndrome.
Petre-Quadens O; De Lee C
J Neurol Sci; 1975 Nov; 26(3):443-53. PubMed ID: 171348
[TBL] [Abstract][Full Text] [Related]
2. Sleep EEG patterns in a case of Down's syndrome--before and after 5-HTP.
Lee JC; Ornitz EM; Tanguay PE; Ritvo ER
Electroencephalogr Clin Neurophysiol; 1969 Sep; 27(7):686. PubMed ID: 4187354
[No Abstract] [Full Text] [Related]
3. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
Partington MW; MacDonald MR
Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
[No Abstract] [Full Text] [Related]
4. The use of 5-HTP in the treatment of Down's syndrome.
Weise P; Koch R; Shaw KN; Rosenfeld MJ
Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
[No Abstract] [Full Text] [Related]
5. [Down's syndrome and serotonin].
Oura T; Uemura I
Saishin Igaku; 1968 Feb; 24(2):328-31. PubMed ID: 4239279
[No Abstract] [Full Text] [Related]
6. The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
Bazelon M; Barnet A; Lodge A; Shelburne SA
Brain Res; 1968 Nov; 11(2):397-411. PubMed ID: 4302675
[No Abstract] [Full Text] [Related]
7. Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.
Bazelon M; Paine RS; Coeiw VA; Hunt P; Houck JC; Mahanand D
Lancet; 1967 May; 1(7500):1130-3. PubMed ID: 4164790
[No Abstract] [Full Text] [Related]
8. Review of drug treatment for Down's syndrome persons.
Share JB
Am J Ment Defic; 1976 Jan; 80(4):388-93. PubMed ID: 2011
[TBL] [Abstract][Full Text] [Related]
9. [Therapy with 5-hydroxytryptophan of Down's disease].
Simonsson H
Nord Med; 1969 Jul; 81(31):952-4. PubMed ID: 4241288
[No Abstract] [Full Text] [Related]
10. Medicinal treatment for relief of hypotonia in Down's Syndrome.
Griffiths MI
Physiotherapy; 1976 Jan; 62(1):19-20. PubMed ID: 130644
[No Abstract] [Full Text] [Related]
11. Decreased arousals among healthy infants after short-term sleep deprivation.
Franco P; Seret N; Van Hees JN; Scaillet S; Vermeulen F; Groswasser J; Kahn A
Pediatrics; 2004 Aug; 114(2):e192-7. PubMed ID: 15286256
[TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptophan and pyridoxine. Their effects in young children with Down's syndrome.
Pueschel SM; Reed RB; Cronk CE; Goldstein BI
Am J Dis Child; 1980 Sep; 134(9):838-44. PubMed ID: 6447999
[TBL] [Abstract][Full Text] [Related]
13. L -5-Hydroxytryptophan treatment of sleep terrors in children.
Bruni O; Ferri R; Miano S; Verrillo E
Eur J Pediatr; 2004 Jul; 163(7):402-7. PubMed ID: 15146330
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness to stimulation during paradoxical sleep in infants.
Dittrichová J; Paul K; Pavlíková E
Early Hum Dev; 1977 Dec; 1(3):213-25. PubMed ID: 214288
[TBL] [Abstract][Full Text] [Related]
15. Sleep patterns in mental retardation: Down's syndrome.
Clausen J; Sersen EA; Lidsky A
Electroencephalogr Clin Neurophysiol; 1977 Aug; 43(2):183-91. PubMed ID: 69529
[TBL] [Abstract][Full Text] [Related]
16. Butoctamide hydrogen succinate and intensive learning sessions: effects on night sleep of Down's syndrome patients.
Gigli GL; Grubar JC; Colognola RM; Amata MT; Pollicina C; Ferri R; Musumeci SA; Bergonzi P
Sleep; 1987 Dec; 10(6):563-9. PubMed ID: 2963363
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-hydroxytryptophan on fragmentation of REM sleep in alcoholics.
Zarcone VP; Hoddes E
Am J Psychiatry; 1975 Jan; 132(1):74-6. PubMed ID: 233794
[TBL] [Abstract][Full Text] [Related]
18. Electromyographic activity and sleep states in infants.
Liefting B; Bes F; Fagioli I; Salzarulo P
Sleep; 1994 Dec; 17(8):718-22. PubMed ID: 7701183
[TBL] [Abstract][Full Text] [Related]
19. 5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats.
Sallanon M; Buda C; Janin M; Jouvet M
Eur J Pharmacol; 1982 Aug; 82(1-2):29-35. PubMed ID: 6215254
[TBL] [Abstract][Full Text] [Related]
20. Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration.
Grubar JC; Gigli GL; Colognola RM; Ferri R; Musumeci SA; Bergonzi P
Psychopharmacology (Berl); 1986; 90(1):119-22. PubMed ID: 2945221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
